Research & Clinical Trials
Breast Cancer Clinical Trials
Johns Hopkins, in collaboration with the University of California Los Angeles and Dana Farber Cancer Institute, is conducting a study, called Pathways to Wellness that focuses on wellness after breast cancer. Researchers are looking to compare two groups, a mindfulness meditation class and survivorship education class, and their impact on meeting the common needs of young survivors. You may be eligible to participate if you:
- Age 50 or younger at the time of breast cancer diagnosis
- Are within five years of your diagnosis
Classes meet for six weeks (one, 2-hour class per week) and are held at Johns Hopkins or nearby. There are also three in-person evaluations throughout the duration of the study. If you are
interested in participating or would like more information, contact the study staff at: 410-614-1361 or HopkinsBreastTrials@jhmi.edu
Research Discoveries Lead to More Individualized Precision Medicine
Cancer is very complex and Johns Hopkins has led the world in deciphering the cellular causes of cancer. Through national and international collaborations with our team of physician scientists across Johns Hopkins University, we continue to change the care path for breast cancer patients by exploring new technologies and developing the most exacting standards of care.
Breast cancer researcher
Groundbreaking discoveries led by our team at the Johns Hopkins Kimmel Cancer Center found that breast cancer is not just one disease but a number of diseases. Several breast cancers might look alike under the microscope, but genetically they are very different. Most breast cancers are caused by a series of changes in normal cells over time. These cellular alterations are red flags or biomarkers which can identify those at risk and can serve as targets for prevention.
Some examples of Breast Cancer Program research include:
Liquid Biopsy Research to Identify Hidden Cancer Cells
As we advance evidence-based treatment protocols for breast cancer, our team of experts work toward the cure of cancer through novel approaches such as liquid biopsies. This non-invasive blood test will be able to identify microscopic, or hidden, cancer cells within the blood. Through focused research, this knowledge could literally determine the future of cancer care. After each step of treatment, our team will be able to determine if there are any residual cancer cells still within the body. This knowledge will then determine next steps so cancer treatment decisions are based on a very personalized approach to care to better limit the short and long term side effects of treatment.
Engaging the Immune System to Fight Breast Cancer
Researchers in the Breast Cancer Program are studying new therapies that may help educate and awaken the immune system's response to breast cancer cells. Working with scientists across Johns Hopkins who are studying how cancer cells evade the immune system, our clinicians are conducting clinical trials to test new therapies aimed at the immune system. These include vaccines that may help immune system cells find breast cancer cells in the body and immunotherapy drugs that target molecules on breast cancer and immune cells.
Epigenetic Therapy Resets the Biological Clock on Breast Cancer Cells
Epigenetics is the term used to describe natural control mechanisms that influence gene expression. Cancer cells use these control mechanisms to survive and spread. Epigenetic therapies target these controls and have shown the ability to reset them to normal, resulting in the death of cancer cells. Breast Cancer Program researchers are studying whether epigenetic-targeted drugs may help overcome resistance to standard breast cancer treatments. They are testing these drugs in combination with other therapies, including immunotherapy drugs aimed at awakening the immune system's response to breast cancer cells.
Breast Cancer Clinical Trials Define Therapy Plans
Breast cancer researcher
Clinical trials advance cancer research and are the only way to find safe and potentially more effective therapies to treat cancer. Patients who enroll in clinical trials have access to new treatments that may offer better results than current treatments. Through breast cancer specific clinical trial research at Johns Hopkins, we are defining individualized therapy plans based on specific breast cancer types and the degree of spread, or how far the cancer has spread from where it originated.
While one of the goals of any cancer treatment is to eliminate the chance of cancer recurrence, we can’t really determine which patients with breast cancer will relapse. With these new breast cancer treatment options discovered through research and clinical trials, our team is now able to significantly lower the percentage of recurrence.